Cargando…
Novel Biomarkers and Druggable Targets in Advanced Melanoma
SIMPLE SUMMARY: Immunotherapy and targeted therapy represent effective therapeutic opportunities that radically changed the available armamentarium for the treatment of melanoma. In about 50% of patients with advanced disease, long-term survival can be achieved; unfortunately, the other half of pati...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750474/ https://www.ncbi.nlm.nih.gov/pubmed/35008245 http://dx.doi.org/10.3390/cancers14010081 |